103 related articles for article (PubMed ID: 26107225)
1. Loss of Expression of PTEN is Associated with Worse Prognosis in Patients with Cancer.
Qiu ZX; Zhao S; Li L; Li WM
Asian Pac J Cancer Prev; 2015; 16(11):4691-8. PubMed ID: 26107225
[TBL] [Abstract][Full Text] [Related]
2. Loss of PTEN expression in breast cancer: association with clinicopathological characteristics and prognosis.
Li S; Shen Y; Wang M; Yang J; Lv M; Li P; Chen Z; Yang J
Oncotarget; 2017 May; 8(19):32043-32054. PubMed ID: 28410191
[TBL] [Abstract][Full Text] [Related]
3. Association of the PTEN IVS4 (rs3830675) gene polymorphism with reduced risk of cancer: evidence from a meta-analysis.
Mandal RK; Akhter N; Irshad M; Panda AK; Ali A; Haque S
Asian Pac J Cancer Prev; 2015; 16(3):897-902. PubMed ID: 25735379
[TBL] [Abstract][Full Text] [Related]
4. Phosphatase and tensin homolog (PTEN) expression on oncologic outcome in renal cell carcinoma: A systematic review and meta-analysis.
Tang L; Li X; Gao Y; Chen L; Gu L; Chen J; Lyu X; Zhang Y; Zhang X
PLoS One; 2017; 12(7):e0179437. PubMed ID: 28672019
[TBL] [Abstract][Full Text] [Related]
5. The prognostic value and potential drug target of phosphatase and tensin homolog in breast cancer patients: A meta-analysis.
Xu F; Zhang C; Cui J; Liu J; Li J; Jiang H
Medicine (Baltimore); 2017 Sep; 96(36):e8000. PubMed ID: 28885360
[TBL] [Abstract][Full Text] [Related]
6. Association between PTEN Gene IVS4 polymorphism and risk of cancer: a meta-analysis.
Sun L; Liu J; Yuan Q; Xing C; Yuan Y
PLoS One; 2014; 9(6):e98851. PubMed ID: 24901890
[TBL] [Abstract][Full Text] [Related]
7. Association between PTEN IVS4 polymorphism and cancer risk: a meta-analysis.
Gao X; Duan H; Zhu Z
Cancer Biomark; 2013 Jan; 13(6):465-70. PubMed ID: 24595084
[TBL] [Abstract][Full Text] [Related]
8. The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis.
Wang Y; Liu Y; Du Y; Yin W; Lu J
Curr Med Res Opin; 2013 Jun; 29(6):633-42. PubMed ID: 23574264
[TBL] [Abstract][Full Text] [Related]
9. PTEN in kidney cancer: A review and meta-analysis.
Que WC; Qiu HQ; Cheng Y; Liu MB; Wu CY
Clin Chim Acta; 2018 May; 480():92-98. PubMed ID: 29408173
[TBL] [Abstract][Full Text] [Related]
10. Relationships between PTEN gene mutations and prognosis in glioma: a meta-analysis.
Xiao WZ; Han DH; Wang F; Wang YQ; Zhu YH; Wu YF; Liu NT; Sun JY
Tumour Biol; 2014 Jul; 35(7):6687-93. PubMed ID: 24705863
[TBL] [Abstract][Full Text] [Related]
11. The association of Phosphatase and tensin homolog (PTEN) deletion and prostate cancer risk: A meta-analysis.
Gao T; Mei Y; Sun H; Nie Z; Liu X; Wang S
Biomed Pharmacother; 2016 Oct; 83():114-121. PubMed ID: 27470558
[TBL] [Abstract][Full Text] [Related]
12. Impact of PTEN IVS4 Polymorphism (rs3830675) on Cancer Susceptibility: An Updated Meta-analysis.
Wang Y; Yang H; Luo JI; Ge J
Cancer Genomics Proteomics; 2015; 12(5):263-9. PubMed ID: 26417029
[TBL] [Abstract][Full Text] [Related]
13. Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non-small cell lung cancer patients and its impact on survival: A systematic review and meta-analysis.
Zhao Y; Zheng R; Li J; Lin F; Liu L
Thorac Cancer; 2017 May; 8(3):203-213. PubMed ID: 28263037
[TBL] [Abstract][Full Text] [Related]
14. FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.
Personeni N; Rimassa L; Verusio C; Barni S; Rubino L; Bozzarelli S; Villa E; Carnaghi C; Tronconi MC; Gerardi C; Galli F; Floriani I; Destro A; Raschioni C; Labianca R; Santoro A
Clin Colorectal Cancer; 2015 Sep; 14(3):162-9. PubMed ID: 25861836
[TBL] [Abstract][Full Text] [Related]
15. PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature.
Xiao J; Hu CP; He BX; Chen X; Lu XX; Xie MX; Li W; He SY; You SJ; Chen Q
Oncotarget; 2016 Sep; 7(36):57832-57840. PubMed ID: 27506936
[TBL] [Abstract][Full Text] [Related]
16. Loss of phosphatase and tensin homolog protein expression is an independent poor prognostic marker in lung adenocarcinoma.
Yanagawa N; Leduc C; Kohler D; Saieg MA; John T; Sykes J; Yoshimoto M; Pintilie M; Squire J; Shepherd FA; Tsao MS
J Thorac Oncol; 2012 Oct; 7(10):1513-21. PubMed ID: 22982652
[TBL] [Abstract][Full Text] [Related]
17. PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.
Gu J; Ou W; Huang L; Wu J; Li S; Xu J; Feng J; Liu B; Zhou Y
Minerva Med; 2016 Oct; 107(5):342-51. PubMed ID: 27333149
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of ERG and Wild-Type PTEN Are Associated with Favorable Clinical Prognosis and Low Biochemical Recurrence in Prostate Cancer.
Kim SH; Kim SH; Joung JY; Lee GK; Hong EK; Kang KM; Yu A; Nam BH; Chung J; Seo HK; Park WS; Lee KH
PLoS One; 2015; 10(4):e0122498. PubMed ID: 25897494
[TBL] [Abstract][Full Text] [Related]
20. Variants on the promoter region of PTEN affect breast cancer progression and patient survival.
Heikkinen T; Greco D; Pelttari LM; Tommiska J; Vahteristo P; Heikkilä P; Blomqvist C; Aittomäki K; Nevanlinna H
Breast Cancer Res; 2011; 13(6):R130. PubMed ID: 22171747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
